Gonadotropin-Releasing and Antimullerian Hormones Levels and Other Hematological Parameters among Females with Polycystic Ovaries at Al-Najaf City

Authors

  • Mohammed Abdulrazzaq Assi
  • Layth Abdulmajeed Abdulkahaleq
  • Makarim Hisham Mohammed
  • Asaad Ali Hussein
  • Baneen Radhi Ali
  • Hawraa Raheem Mehdi
  • Rafal Basim Mohammed
  • Zahraa Qasim Selman

Abstract

Objectives: To evaluate the hormonal parameters efficacy as markers for polycystic Ovaries in women.

Methodology: This is a case-control study containing fourteen samples of female polycystic ovarian patients. According to age, it is separated into four groups. Their ages ranged from 15 to 55 years old. Between October 2021 and February 2022, samples were obtained from patients at Al-Sadder Hospital center / Najaf Ashraf. A total of fourteen volunteers were used as a control group in this investigation. The study is explained to both the patients and controls group.

Results: The age difference between the cases and the controls was not significant. Residence, or education. Between women with PCOS and controls, none of the hematological markers showed any significant changes. (e.g., HGB, RBC, WBC, and platelet). The mean LH, PRL, FSH and AMH, DHEA was significantly higher in those with polycystic ovarian syndrome Patients in Comparison with Control (P < .001).

Conclusion: The study concluded that AMH and DHEA hormones play vital roles in polycystic Ovaries, An overabundance of androgens damages the endocrine and immunological systems, as well as causing metabolic changes.

Downloads

Published

2022-10-11